IMCR

Conviction 22HealthcareScan · Fri, Jun 26, 2026

IMCR$30.83+0.95%

ResistanceSupportVol 14

Vol MA14 602.13K

Mar 27Apr 15May 4May 20Jun 9Jun 26

Immunocore Holdings plcBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.immunocore.com ↗

Price30.83

Change+0.95%

Gap+0.85%

Rel volume1.21×

Avg volume582.01K

Avg $ vol17M

SMA 2028.95

SMA 5029.15

SMA 20032.61

Price vs 50+5.77%

Price vs 200-5.45%

MA stackmixed

50/200 cross—

Supertrenddown · 31.70

RSI (14)63

MACD hist0.29

MACD crossbull · 9d

Stoch %K / %D81 / 81

ADX (14)14

+DI / −DI22 / 11

RSI divergence—

MACD divergence—

ATR %+3.89%

ADR %4.08%

52w high40.22

52w low27.79

From 52w high-23.34%

Above 52w low+10.94%

New 52w highNo

SqueezeFired

Bollinger width10.74%

%B1.11

Donchian pos80.50%

Donchian high31.62

Donchian low27.59

AVWAP (52w high)31.51

vs AVWAP high-2.16%

AVWAP (52w low)29.15

vs AVWAP low+5.76%

OBV trendUp

Chaikin MF (20)-0.02

Today vs 20d1.21×

Avg vol (14d)602.13K

Avg vol (20d)582.01K

Avg $ vol (20d)17M

Market cap—

RS 3m (vs SPY)-10.94%

RS 6m (vs SPY)-22.34%

RS line new highNo

Trend template2/8

Technical rank46.3

1 week+7.80%

1 month+8.10%

3 months+1.05%

6 months-14.81%

1 year-3.69%

YTD-8.73%

P/E-43.81

P/B3.95

P/S3.89

P/FCF-103.37

EPS-0.7100

Div yield—

ROE-9.02%

ROA-3.31%

Debt/Eq1.11

Current4.18

EV/EBITDA-36.49

Gross margin—

Net margin-8.88%

Rev growth28.95%

EPS growth30.48%

Price target69.71

Target upside127.88%

Analyst ratingBuy

Institutional104.10%

Ent. value1.54B

Revenue106.68M

Net income12.97M

Gross profit—

Free cash flow-15.05M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out50.87M

Employees524

ListedFri, Feb 5, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction22 / 100

Pattern quality—

Tech rank46.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance30.85

Support27.63

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IMCR

All disclosures →

No recent disclosed trades by Congress in IMCR. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMCR · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Peterson Kristine Director · Share Option (Right to Buy) · 2026-05-27	Grant	27.49K	$0	2026-05-27	2026-05-28
Herbst Roy Steven Director · Share Option (Right to Buy) · 2026-05-27	Grant	27.49K	$0	2026-05-27	2026-05-28
Ratcliffe Peter John Director · Share Option (Right to Buy) · 2026-05-27	Grant	27.49K	$0	2026-05-27	2026-05-28
Bell John Irving Director · Share Option (Right to Buy) · 2026-05-27	Grant	27.49K	$0	2026-05-27	2026-05-28
Pao William Director · Share Option (Right to Buy) · 2026-05-27	Grant	27.49K	$0	2026-05-27	2026-05-28
Kaul Siddharth Director · Share Option (Right to Buy) · 2026-05-27	Grant	27.49K	$0	2026-05-27	2026-05-28

SEC filings

EDGAR filings in IMCR

EDGAR →

No recent SEC filings on file for IMCR.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.